Your browser doesn't support javascript.
loading
CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study.
Wei, Guoqing; Zhang, Yanlei; Zhao, Houli; Wang, Yiyun; Liu, Yandan; Liang, Bin; Wang, Xiujian; Xu, Huijun; Cui, Jiazhen; Wu, Wenjun; Zhao, Kui; Nagler, Arnon; Chang, Alex H; Hu, Yongxian; Huang, He.
Afiliación
  • Wei G; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Zhang Y; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Zhao H; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Wang Y; Shanghai YaKe Biotechnology Ltd., Shanghai, China.
  • Liu Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Liang B; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Wang X; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Xu H; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Cui J; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Wu W; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Zhao K; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Nagler A; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Chang AH; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Hu Y; Department of Hematology, Wenzhou Medical University, Wenzhou, China.
  • Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Cancer Immunol Res ; 9(9): 1061-1070, 2021 09.
Article en En | MEDLINE | ID: mdl-34290048
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Trasplante de Células Madre Hematopoyéticas / Receptores Quiméricos de Antígenos / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Trasplante de Células Madre Hematopoyéticas / Receptores Quiméricos de Antígenos / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos